SARS-CoV-2 humoral immunity is associated with elevated hemoglobin A1c
Laboratory Medicine · 2026
DOI: 10.1093/labmed/lmaf036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, 2026. Verfasst von Darryl E Palmer-Toy und 10 weiteren Autor:innen. Beteiligte Einrichtung: Southern California Permanente Medical Group Regional Reference Laboratories, North Hollywood & Chino Hills, CA, United States. Hauptthemen laut MEDLINE: COVID-19, Glycated Hemoglobin, SARS-CoV-2, Immunity, Humoral. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Kaiser Permanente Garfield Memorial Research Fund, Kaiser Permanente Community Health Fund.
Abstract (Originalsprache)
Introduction
This prospective study assessed relationships between COVID-19, humoral immunity, and common laboratory test results.
Methods
Blood and urine were collected from adults with clinical SARS-CoV-2 test results before August 2021: nucleic acid amplification (NAA) tests and antinucleocapsid protein (αN) serology. Measurements were made of αN and 13 laboratory tests, and results were compared across groups defined by NAA and αN status.
Results
Glycated hemoglobin (HbA1c) and platelet counts were clinically significantly higher among individuals who had COVID-19 than in individuals without evidence of COVID-19. Hemoglobin was more abnormal among patients without evidence of COVID-19. Glycated hemoglobin results were also much higher among patients with prior positive NAA and current or prior positive αN results than in individuals with negative αN results. No other statistically significant associations between NAA or αN and abnormal laboratory results were found.
Discussion
Elevated HbA1c results were associated with prior positive NAA findings combined with positive αN results but not with negative αN results. Further investigation into the association of dysregulated glycemic control with humoral immunity to natural infection is warranted, given the well-documented increase in incidence in type 1 and type 2 diabetes following COVID-19. Prior positive NAA results were also associated with a few nonspecific abnormalities of the complete blood cell count.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Southern California Permanente Medical Group Regional Reference Laboratories, North Hollywood & Chino Hills, CA, United States.
- Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena, CA, United States.
- Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, United States.
- Department of Clinical Analysis, Southern California Permanente Medical Group, Pasadena, CA, United States.
- School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States.
- Colorado School of Public Health, University of Colorado School of Medicine, Aurora, CO, United States.
ORCID-Profile: John M Chang, Ingrid A Binswanger
Förderung
- Kaiser Permanente Garfield Memorial Research Fund
- Kaiser Permanente Community Health Fund
Zitieren
APA
Palmer-Toy, D. E., Yan, R., Narwaney, K. J., Legaspi, A., Aragones, M., Lam, J. A., Chang, J. M., Portugal, C., Bruxvoort, K. J., Glanz, J. M., & Binswanger, I. A. (2026). SARS-CoV-2 humoral immunity is associated with elevated hemoglobin A1c. Laboratory Medicine. https://doi.org/10.1093/labmed/lmaf036
Vancouver
Palmer-Toy DE, Yan R, Narwaney KJ, Legaspi A, Aragones M, Lam JA, et al. SARS-CoV-2 humoral immunity is associated with elevated hemoglobin A1c. Laboratory Medicine. 2026. doi:10.1093/labmed/lmaf036
BibTeX
@article{PalmerToy2026,
author = {Palmer-Toy, Darryl E and Yan, Rui and Narwaney, Komal J and Legaspi, Aida and Aragones, Michael and Lam, Jessica A and Chang, John M and Portugal, Cecilia and Bruxvoort, Katia J and Glanz, Jason M and Binswanger, Ingrid A},
title = {SARS-CoV-2 humoral immunity is associated with elevated hemoglobin A1c},
journal = {Laboratory Medicine},
year = {2026},
doi = {10.1093/labmed/lmaf036}
}
EUVIMED